Comparative Pharmacology
Head-to-head clinical analysis: CIPRO HC versus FORBAXIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CIPRO HC versus FORBAXIN.
CIPRO HC vs FORBAXIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ciprofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing DNA replication and transcription; hydrocortisone suppresses inflammation via glucocorticoid receptor activation.
FORBAXIN is a prodrug of the active moiety cefditoren, a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Instill 3 drops into the affected ear(s) twice daily (morning and evening) for 7 days.
IV: 500 mg every 12 hours, infused over 30 minutes.
None Documented
None Documented
Ciprofloxacin: 4-6 hours (prolonged to 6-9 hours in elderly or renal impairment). Hydrocortisone: 1-2 hours.
8-12 hours; prolonged in renal impairment (up to 24 hours in severe cases)
Ciprofloxacin: ~50-70% excreted renally as unchanged drug, ~15% as metabolites; ~20-30% eliminated via biliary/fecal route. Hydrocortisone: metabolized hepatically, renal excretion of metabolites.
Renal (60-70% unchanged), biliary/fecal (20-30%)
Category C
Category C
Antibiotic/Corticosteroid Combination (Otic)
Antibiotic